A retrospective observational study of changes in uterine fibroid blood flow and fibroid diameter after administration of gonadotropin‐releasing hormone agonists and antagonists using superb microvascular imaging
In the treatment of uterine fibroids with relugolix, a reduction in fibroid blood flow assessed by SMI may suggest a subsequent reduction in fibroid size. These results provide useful insights when making the decision whether or not to continue relugolix administration.
Authors
- Naoki Yoshikawa (ORCID: https://orcid.org/0000-0002-4928-0395)
- Yoshihiro Nishijima
- Minako Katano
- Hiroaki Fujita (ORCID: https://orcid.org/0000-0001-7344-0750)
- Eri Nakano (ORCID: https://orcid.org/0000-0001-8305-1767)
- Aya Shiraiwa
- Akane Takaya
- Yoshiya Furusawa (ORCID: https://orcid.org/0000-0003-4213-7331)
- Reiko Kitayama
- Keiko Hirayama
- Reiko Numazaki
- Yudai Tanaka (ORCID: https://orcid.org/0000-0002-3177-7416)
- Eri Obiya
Publication Details
- Journal
- Journal of obstetrics and gynaecology research
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/jog.16361
- Citations
- 1
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06